"
Team:Freiburg
From 2013.igem.org
| Line 10: | Line 10: | ||
text-decoration: none; | text-decoration: none; | ||
overflow:none; | overflow:none; | ||
| + | } | ||
| + | |||
| + | #tour { | ||
| + | float: left; | ||
| + | } | ||
| + | |||
| + | #tour img { | ||
| + | width: 450px; | ||
| + | |||
| + | } | ||
| + | |||
| + | #kachel_project { | ||
| + | float:right; | ||
| + | } | ||
| + | |||
| + | #kachel_project img { | ||
| + | width: 450px; | ||
| + | } | ||
| + | |||
| + | #kachel_tool { | ||
| + | |||
| + | } | ||
| + | |||
| + | #kachel_tool img { | ||
| + | width:225px; | ||
| + | } | ||
| + | |||
| + | #kachel_team { | ||
| + | |||
| + | } | ||
| + | |||
| + | #kachel_team img { | ||
| + | width: 225px; | ||
} | } | ||
| Line 62: | Line 95: | ||
| - | <div id=" | + | <div id="tour"> |
| - | <img src="https://static.igem.org/mediawiki/2013/ | + | <img src="https://static.igem.org/mediawiki/2013/b/bc/Cas9_tour.png"> |
| + | </div> | ||
| + | |||
| + | <div id="kachel_project"> | ||
| + | <img src="https://static.igem.org/mediawiki/2013/d/d2/Project_kachel.png"> | ||
| + | </div> | ||
| + | |||
| + | <div id="kachel_tool"> | ||
| + | <img src="https://static.igem.org/mediawiki/2013/9/9e/Tool_kachel_2.png"> | ||
| + | </div> | ||
| + | |||
| + | <div id="kachel_team"> | ||
| + | <img src="https://static.igem.org/mediawiki/2013/f/fb/Team_kachel.png"> | ||
</div> | </div> | ||
Revision as of 20:20, 25 August 2013
Gene Regulation – Multiple Targets – Activation – Optogenetics – Repression – Inducibility – Epigenetics
Just imagine there was a tool that combined all these aspects of lab work. A tool, that was able to rule several genes at once; a tool that allowed highly specific gene modulation via stimulus induction; a tool that would be a new approach to gene regulation.
This year’s Freiburg iGEM Team uses the prokaryotic CRISPR/Cas system to enable multiple endogenous gene regulation with minimal effort. The regulation is based on a protein-RNA-DNA interaction. Customizable RNAs function as a guide for our protein in order to target specific DNA sequences. By fusing effector domains to this protein, we aim at developing a tool for multiple and inducible gene activation and repression. Despite the system's prokaryotic origin, gene target sequences are adjustable for various organisms, offering a broad application variety of our tool. Due to its great potential, the CRISPR/Cas system has become of increasing importance in current research and can be implemented in a number of novel and interesting applications, such as gene therapy or tissue engineering.
